ACTIVE BETWEEN: 2018-2021
China TB Case Finding Strategic Partnership Program
Johnson & Johnson collaborated with the China CDC to improve TB and RR-TB case detection across several regions in China covering 10 million people.
Objectives
The initiative was aimed at improving TB case detection and patient finding across several regions of China.
From 2018-2021, Johnson & Johnson collaborated with the National Health Commission (NHC), China CDC and Cepheid to improve TB/MDR-TB patient detection for 10 million individuals in 22 counties of 3 western provinces by introducing quick diagnostic technology and performing medical trainings for local health care providers.
Geographic Reach
- Western Pacific
Disease Area
- Infectious and Parasitic Disease
Geographic Reach
Western Pacific
- China
Disease Area
Infectious and Parasitic Disease
- Drug-Resistant Infections (AMR)
- Tuberculosis